The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
4.000
-0.070 (-1.72%)
May 8, 2026, 4:00 PM EDT - Market closed

The Oncology Institute Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
39542123151121874
Market Cap Growth
39.47%1698.25%-84.53%25.12%-86.16%834.75%
Enterprise Value
469.93483.8190.09181.71149.76758.43
Last Close Price
4.003.560.312.041.659.75
PE Ratio
--6.59-0.44-2.22-7.86-60.94
PS Ratio
0.720.840.060.470.484.30
PB Ratio
--26.776.522.650.988.39
P/TBV Ratio
-24.19-20.926.462.641.086.20
P/FCF Ratio
--15.15-0.77-3.70-1.80-24.59
P/OCF Ratio
--17.12-0.88-4.17-1.96-26.73
EV/Sales Ratio
0.860.960.230.560.593.74
EV/EBITDA Ratio
--16.60-1.67-2.55-1.93-17.84
EV/EBIT Ratio
--13.41-1.50-2.36-1.83-16.54
EV/FCF Ratio
--17.41-2.97-4.44-2.23-21.35
Debt / Equity Ratio
-5.98-6.1432.421.990.830
Debt / EBITDA Ratio
-4.05-3.56-2.29-1.68-1.390.00
Debt / FCF Ratio
-4.08-3.73-4.06-2.93-1.610.00
Net Debt / Equity Ratio
-4.58-4.4620.480.650.28-1.10
Net Debt / EBITDA Ratio
-2.88-2.41-1.36-0.52-0.442.71
Net Debt / FCF Ratio
-2.90-2.52-2.42-0.90-0.513.24
Asset Turnover
3.542.982.061.381.091.51
Inventory Turnover
54.9631.6828.6223.0825.5330.05
Quick Ratio
1.131.311.883.623.844.58
Current Ratio
1.171.592.154.124.395.17
Return on Equity (ROE)
271.91%999.19%-213.36%-92.20%0.13%-16.52%
Return on Assets (ROA)
-21.12%-21.44%-31.48%-32.72%58.86%-36.05%
Return on Invested Capital (ROIC)
-59.79%-49.91%-68.47%-58.91%123.16%-102.02%
Return on Capital Employed (ROCE)
-41.30%-33.69%-40.76%-37.90%-40.41%-43.52%
Earnings Yield
-7.61%-15.17%-229.77%-45.10%-12.73%-1.64%
FCF Yield
-6.51%-6.60%-129.59%-27.03%-55.66%-4.07%
Buyback Yield / Dilution
-30.10%-23.11%-1.76%8.51%-21.70%-12.03%
Total Shareholder Return
-30.10%-23.11%-1.76%8.51%-21.70%-12.03%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q